Publikationen

Publikationen

  • Mostert V, Bonifay S, Dobe C, Fliege R, Krass J, Vosswinkel R, Wormuth M (2019) REACH Worker Exposure Model for Co-formulants Used in Plant Protection Products. Ann Work Expo Health 63(1): 54–67

  • Dobe C, Bonifay S, Fliege R, Krass J, Mostert V, Vosswinkel R, Wormuth M (2016) Development of REACH Generic Exposure Scenarios for Substances Used as Coformulants in Plant Protection Products. Risk Anal 37(5): 930-942

  • Greim H, Saltmiras D, Mostert V, Strupp C (2015) Evaluation of carcinogenic potential of the herbicide glyphosate, drawing on tumor incidence data from fourteen chronic/carcinogenicity rodent studies. Crit Rev Toxicol 45(3): 185-208

  • Aggarwal M, Battalora M, Fisher P, Hüser A, Parr-Dobrzanski R, Soufi M, Mostert V, Strupp C, Whalley P, Wiemann C, Billington R (2014) Assessment of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption. Reg Toxicol Pharmacol 68(3): 412-423.

  • Forceville X, Mostert V, et al. (2009) Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes. Eur Surg Res 43(4):338-47.

  • Burk RF, Hill KE, Nakayama A, Mostert V, et al. (2008) Selenium deficiency activates mouse liver Nrf2-ARE but vitamin E deficiency does not. Free Radic Biol Med 44(8):1617-23.

  • Mostert V, Nakayama A, Austin LM, Levander XA, Ferris CD, Hill KE, Burk RF (2007) Serum iron increases with acute induction of hepatic heme oxygenase-1 in mice. Drug Metab Rev 39(2-3):619-26.

  • Mostert V, Hill KE, Ferris CD, Burk RF (2003) Selective induction of liver parenchymal cell heme oxygenase-1 in selenium-deficient rats. Biol Chem 384(4):681-7.

  • Mostert V, Hill KE, Burk RF (2003) Loss of activity of the selenoenzyme thioredoxin reductase causes induction of hepatic heme oxygenase-1. FEBS Lett 541(1-3):85-8.

  • Mostert V, Wolff S, Dreher I, Köhrle J, Abel J (2001) Identification of an element within the promoter of human selenoprotein P responsive to transforming growth factor-beta. Eur J Biochem268(23):6176-81.

  • Mostert V, Dreher I, Köhrle J, Wolff S, Abel J (2001) Modulation of selenoprotein P expression by TGF-beta(1) is mediated by Smad proteins. Biofactors 14(1-4):135-42.

  • Wolff S, Harper PA, Wong JM, Mostert V, Wang Y, Abel J (2001) Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1). Mol Pharmacol59(4):716-24.

  • Mostert V (2000) Selenoprotein P: properties, functions, and regulation. Arch Biochem Biophys376(2):433-8. Review.

  • Mostert V, Dreher I, Köhrle J, Abel J (1999) Transforming growth factor-beta1 inhibits expression of selenoprotein P in cultured human liver cells. FEBS Lett460(1):23-6.

  • Arteel GE, Mostert V, Oubrahim H, Briviba K, Abel J, Sies H (1998) Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration. Biol Chem 379(8-9):1201-5.

  • Mostert V, Lombeck I, Abel J (1998) A novel method for the purification of selenoprotein P from human plasma. Arch Biochem Biophys357(2):326-30.